Close
Smartlab Europe
Inizio Ignite

Xcellerex launches new bag-type XDR-10 single-use bioreactor

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.

Lipid-Based Drug Delivery System for Low-Soluble Drugs

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.
- Advertisement -

Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor.

The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l.

The XDR-10 is an integral component of the Xcellerex FlexFactory modular biomanufacturing platform that leverages single-use technology and advanced process automation.

The new system features a low shear, high input-power impeller with optimized position which maximizes volume range and turndown ratio.

The XDR-10 can function as a production vessel in its own right, or become a scale-down tool or satellite platform for larger projects to be continued in larger bioreactors, according to the company.

The flexible platform enables biomanufacturers to speed up deployment of new manufacturing capacity with reduced capital costs and lowered risk.

Latest stories

Related stories

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.

Lipid-Based Drug Delivery System for Low-Soluble Drugs

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.

Formulation Strategies for Improving Drug Bioavailability

Analysis of the chemical and physical methodologies employed to overcome solubility and permeability barriers, ensuring active pharmaceutical ingredients reach systemic circulation effectively.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »